Arterial thrombosis in patients with malignant diseases: definition, features, diagnostics, treatment. Literature review. Рart 2
https://doi.org/10.52727/2078-256X-2025-21-2-204-213
Abstract
Malignant neoplasms and antitumor therapy increase the risk of arterial thromboembolism (ischemic stroke, acute arterial occlusion of peripheral arteries). The article presents the incidence of ATE in these patients, the risk factors for the development of ATE depending on the type of caner, as well as the prevention and treatment of ATE complications in patients with cancer.
About the Authors
D. V. Kozlov
State Budgetary Healthcare Institution of the city of Moscow “F.I. Inozemtsev City Clinical Hospital of the Department of Health of the City of Moscow”
Russian Federation
Russian Federation
Denis V. Kozlov, candidate of medical sciences, cardiovascular surgeon
1, Fortunatovskaya st., Moscow, 105187
A. I. Zagorulko
Oncological Center No. 1 of the State Budgetary Healthcare Institution of the city of Moscow “S.S. Yudin City Clinical Hospital of the Department of Health of the City of Moscow”
Russian Federation
Russian Federation
Alexey I. Zagorulko, candidate of medical sciences, head of the department of X-ray endovascular methods of diagnosis and treatment No. 2
G. P. Nistratov
Oncological Center No. 1 of the State Budgetary Healthcare Institution of the city of Moscow “S.S. Yudin City Clinical Hospital of the Department of Health of the City of Moscow”
Russian Federation
Russian Federation
Grigory P. Nistratov, candidate of medical sciences, doctor at the department of X-ray endovascular methods of diagnosis and treatment No. 2
18a, build. 7, Zagorodnoye higw., Moscow, 117152
S. P. Rykov
Oncological Center No. 1 of the State Budgetary Healthcare Institution of the city of Moscow “S.S. Yudin City Clinical Hospital of the Department of Health of the City of Moscow”
Russian Federation
Russian Federation
Stanislav P. Rykov, doctor at the department of X-ray endovascular methods of diagnosis and treatment No. 2
18a, build. 7, Zagorodnoye higw., Moscow, 117152
References
1. Costamagna G., Hottinger A., Milionis H., Lambrou D., Salerno A., Strambo D., Livio F., Navi B.B., Michel P. Clinical and demographic characteristics, mechanisms, and outcomes in patients with acute ischemic stroke and newly diagnosed or known activecancer. Neurology, 2023; 100 (24): e2477‒e2489. doi: 10.1212/WNL.0000000000207341
2. Navi B.B., Reiner A.S., Kamel H., Iadecola C., Okin P.M., Elkind M.S.V., Panageas K.S., DeAngelis L.M. Risk of arterial thromboembolism in patients with cancer. J. Am. Coll. Cardiol., 2017; 70 (8): 926‒938. doi: 10.1016/j.jacc.2017.06.047
3. Mulder F.I., Horváth-Puhó E., van Es N., Pedersen L., Büller H.R., Bøtker H.E., Sørensen H.T. Arterial thromboembolism in cancer patients: a danish population-based cohort study. JACC CardioOncol., 2021; 3 (2): 205‒218. doi: 10.1016/j.jaccao.2021.02.007
4. Navi B.B., Reiner A.S., Kamel H., Iadecola C., Elkind M.S, Panageas K.S., DeAngelis L.M. Association between incident cancer and subsequent stroke. Ann. Neurol., 2015; 77 (2): 291‒300. doi: 10.1002/ana.24325
5. Chen P.C., Muo C.H., Lee Y.T., Yu Y.H., Sung F.C. Lung cancer and incidence of stroke: a population-based cohort study. Stroke, 2011; 42 (11): 3034‒309. doi: 10.1161/STROKEAHA.111.615534
6. Kuan A.S., Teng C.J., Wu H.H., Su V.Y., Chen Y.T., Chien S.H.., Yeh CM., Hu L.Y., Chen T.J., Tzeng C.H., Liu C.J. Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study. BMC Med., 2014; 12: 53. doi: 10.1186/1741-7015-12-53
7. Navi B.B., Singer S., Merkler A.E., Cheng N.T., Stone J.B., Kamel H., Iadecola C., Elkind M.S., DeAngelis L.M. Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology, 2014; 83 (1): 26‒33. doi: 10.1212/WNL.0000000000000539
8. Sonbol Y.T., Elgenidy A., Awad A.K., Elmehrath A.O., Kobeissi H., Afifi A.M., Ghozy S. Stroke as a cause of death in patients with cancer: a SEER-based study. J. Stroke Cerebrovasc. Dis., 2023; 32 (8): 107154. doi: 10.1016/j.jstrokecerebrovasdis.2023.107154
9. Dittrich T.D., Aujesky M., Rudin S., Zietz A., Wagner B., Polymeris A., Altersberger V.L., Sinnecker T., Gensicke H., Engelter S.T., Lyrer P., Hess V., Sutter R., Nickel C.H., Bonati L.H., Fischer U., Psychogios M., Katan M., De Marchis G.M. Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications ‒ the PLEURA study. Eur. Stroke J., 2023; 8 (2): 549‒556. doi: 10.1177/23969873231151488
10. Ha J., Lee M.J.., Kim S.J., Park B.Y., Park H., Cho S., Chung J.W., Seo W.K., Kim G.M., Bang O.Y., Chung C.S. Prevalence and impact of venous and arterial thromboembolism in patients with embolic stroke of undetermined source with or without active cancer. J. Am. Heart. Assoc., 2019; 8 (21): e013215. doi: 10.1161/JAHA.119.013215
11. Brenner B., Bikdeli B., Tzoran I., Madridano O., Lуpez-Reyes R., Suriñach J.M., Blanco-Molina Á., Tufano A., Núñez J.J.L., Trujillo-Santos J., Monreal M. RIETE Investigators. Arterial ischemic events are a major complication in cancer patients with venous thromboembolism. Am. J. Med., 2018; 131 (9): 1095‒1103. doi: 10.1016/j.amjmed.2018.04.037
12. Sun M.Y., Bhaskar S.M.M. bridging the gap in cancer-related stroke management: update on therapeutic and preventive approaches. Int. J. Mol. Sci., 2023; 24 (9): 7981. doi: 10.3390/ijms24097981
13. Fitzpatrick T., Carrier M., Le Gal G. Cancer, atrial fibrillation, and stroke. Thromb. Res., 2017; 155: 101‒105. doi: 10.1016/j.thromres.2017.05.006
14. Lun R., Roy D.C., Hao Y., Deka R., Huang W.K., Navi B.B., Siegal D.M., Ramsay T., Fergusson D., Shorr R., Dowlatshahi D. Incidence of stroke in the first year after diagnosis of cancer-A systematic review and meta-analysis. Front. Neurol., 2022; 13: 966190. doi: 10.3389/fneur.2022.966190
15. Navi B.B., Kasner S.E., Elkind M.S.V., Cushman M., Bang O.Y., DeAngelis L.M. Cancer and embolic stroke of undetermined source. Stroke, 2021; 52 (3): 1121‒1130. doi: 10.1161/STROKEAHA.120.032002
16. Bamias A., Tzannis K., Zakopoulou R., Sakellakis M., Dimitriadis J., Papatheodoridi A., Rallidis L., Halvatsiotis P., Tsiara A., Kaparelou M., Kostouros E., Barbarousi D., Koutsoukos K., Fragiadis E., Dellis A.E., Anastasiou I., Stravodimos K., Pinitas A., Papatsoris A., Adamakis I., Varkarakis I., Fragoulis C., Pagoni S., Matsouka C., Skolarikos A., Mitropoulos D., Doumas K., Deliveliotis C., Constantinides C., Dimopoulos M.A. Risk for arterial thromboembolic events (ATEs) in patients with advanced urinary tract cancer (aUTC) treated with firstline chemotherapy: single-center, observational study. Curr. Oncol., 2022; 29 (9): 6077‒6090. doi: 10.3390/curroncol29090478
17. Виценя М.В., Агеев Ф.Т., Гиляров М.Ю., Овчинников А.Г., Орлова Р.В., Полтавская М.Г., Сычева Е.А. Практические рекомендации по коррекции кардиоваскулярной токсичности противоопухолевой лекарственной терапии. Злокачественные опухоли, 2019: 9 (3S2): 609–627. doi: 10.18027/22245057-2019-9-3s2-609-627 [Vitsenya M.V., Ageev F.T., Gilyarov M.Yu., Ovchinnikov A.G., Orlova R.V., Poltavskaya M.G., Sycheva E.A. Practical recommendations for the correction of cardiovascular toxicity of antitumor drug therapy. Malignant tumors, 2019: 9 (3S2): 609–627. (In Russ.)]. doi: 10.18027/22245057-2019-9-3s2-609-627
18. Yhim H.Y., Lee J., Kim K.H., Kim S.A., Lee J.Y., Hwang H.G., Hong J., Lee J.O., Bang S.M. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximabbased combination chemotherapy: A population-based study in Korea. Thromb. Res., 2023; 231: 50‒57. doi: 10.1016/j.thromres.2023.10.005
19. Kelly A., Toale C., Moloney M.A., Kavanagh E.G. Outcomes of acute limb ischaemia in patients with underlying malignancy: a systematic review. EJVES Vasc. Forum, 2021; 54: 13‒20. doi: 10.1016/j.ejvsvf.2021.10.019
20. Sundbøll J., Veres K., Horváth-Puhó E., Adelborg K., Sørensen H.T. Risk and prognosis of cancer after lower limb arterial thrombosis. Circulation, 2018; 138 (7): 669‒677. doi: 10.1161/CIRCULATIONAHA.117.032617
21. Valent P., Hadzijusufovic E., Schernthaner G.H., Wolf D., Rea D., le Coutre P. Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors. Blood, 2015; 125 (6): 901‒906. doi: 10.1182/blood-2014-09-594432
22. El Sakka K., Gambhir R.P.S., Halawa M., Chong P., Rashid H. Association of malignant disease with critical leg ischaemia. Br. J .Surg., 2005; 92: 1498–1501. doi:10.1002/bjs.5125
23. Tsang J.S., Naughton P.A., O’Donnell J., Wang T.T., Moneley D.S., Kelly C.J., Leahy A.L. Acute limb ischemia in cancer patients: should we surgically intervene? Ann. Vasc. Surg., 2011; 25 (7): 954‒960. doi: 10.1016/j.avsg.2011.06.002
24. Larsen T.L., Brekke J., Garresori H., Frøen H., Jacobsen E.M., Torfoss D., Wik H.S., Enden T.R., Porojnicu A.C., Quist-Paulsen P., Velle E., Sandset P.M., Ree A.H., Dahm A.E.A. Arterial thromboembolism in cancer patients treated with apixaban. Blood, 2022; 140 (Supp. 1): 11366–11367. doi: 10.1182/ blood-2022-160363
25. Lesterhuis W.J., van Spronsen D.J., SchultzeKool L.J., de Mulder P.H. Acute arterial occlusion after chemotherapy for testicular cancer. Lancet Oncol., 2005; 6 (11): 910. doi: 10.1016/S1470-2045(05)70428-9
26. Grilz E., Königsbrügge O., Posch F., Schmidinger M., Pirker R., Lang I.M., Pabinger I., Ay C. Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer. Haematologica, 2018; 103 (9): 1549‒1556. doi: 10.3324/haematol.2018.192419
27. Lapébie F.X., Aboyans V., Lacroix P., Constans J., Boulon C., Messas E., Ferrières J., Bongard V., BuraRivière A. Editor’s choice ‒ External applicability of the COMPASS and VOYAGER-PAD trials on patients with symptomatic lower extremity artery disease in France: The COPART registry. Eur. J. Vasc. Endovasc. Surg., 2021; 62 (3): 439‒449. doi: 10.1016/j.ejvs.2021.05.028
28. Nicolajsen C.W., Dickenson M.H., Budtz-Lilly J., Eldrup N. Frequency of cancer in patients operated on for acute peripheral arterial thrombosis and the impact on prognosis. J. Vasc. Surg., 2015; 62 (6): 1598‒1606. doi: 10.1016/j.jvs.2015.06.223
29. Govsyeyev N., Malgor R.D., Hoffman C., Harroun N., Sturman E., Al-Musawi M., Malgor E.A., Jacobs D.L., Nehler M. A systematic review and meta-analysis of outcomes after acute limb ischemia in patients with cancer. J. Vasc. Surg., 2021; 74 (3): 1033‒1040.e1. doi: 10.1016/j.jvs.2021.03.058
30. Javid M., Magee T.R., Galland R.B. Arterial thrombosis associated with malignant disease. Eur. J. Vasc. Endovasc. Surg., 2008; 35 (1): 84‒87. doi: 10.1016/j.ejvs.2007.08.014
31. Morris-Stiff G., Lewis M.H. Surgical treatment of acute limb ischaemia in the presence of malignancy. Int. J. Surg., 2010; 8 (3): 233‒235. doi: 10.1016/j.ijsu.2010.01.007
32. Pernod G., Cohen A., Mismetti P., Sanchez O., Mahé I. INNOVTE CAT Working Group. Cancerrelated arterial thromboembolic events. Arch. Cardiovasc. Dis., 2024; 117 (1): 101‒113. doi: 10.1016/j.acvd.2023.11.007
33. Liu Y., Wang J., Guo L., Ping L. Risk factors of embolism for the cardiac myxoma patients: a systematic review and metanalysis. BMC Cardiovasc. Disord., 2020; 20 (1): 348. doi: 10.1186/s12872-02001631-w
34. Chandler C. Malignant arterial tumor embolization. J. Surg. Oncol., 1993; 52 (3): 197‒202. doi: 10.1002/jso.2930520317
35. Hussain S.M.A. Tumor embolism and acute arterial occlusion: A systematic review. Surgery Open Science, 2022; 10: 216–222. doi.org/10.1016/j. sopen.2022.10.006
36. Qin Y., Zhang L., Liang X., Sun X., Wang N., Yuan M., Wang Q., Wu D. Venous and arterial thromboembolism in patients with metastatic lung cancer. Clin. Appl. Thromb. Hemost., 2023; 29: 10760296231159121. doi: 10.1177/10760296231159121
37. Mitrovic M., Pantic N., Sabljic N., Bukumiric Z., Virijevic M., Pravdic Z., Cvetkovic M., Rajic J., Bodrozic J., Milosevic V., Todorovic-Balint M., Vidovic A., Suvajdzic-Vukovic N., Antic D. Arterial thrombosis in patients with acute myeloid leukemia: incidence and risk factors. Cancers (Basel), 2023; 15 (11): 3060. doi: 10.3390/cancers15113060
38. Akabane K., Watanabe T., Tajima Y., Toyama S., Tamate Y., Uchida T. Case Report: Acute arterial occlusion of the right lower extremity due to left atrial invasion from pulmonary metastases of thyroid cancer. Front. Cardiovasc. Med., 2023; 10: 1221180. doi: 10.3389/fcvm.2023.1221180
39. Abraham K.P., Reddy V., Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am. J. Cardiovasc. Pathol., 1990; 3 (3): 195‒198.
40. Klatt E.C., Heitz D.R. Cardiac metastases. Cancer, 1990; 65 (6): 1456‒1459. doi: 10.1002/1097-0142(19900315)65:6<1456::aidcncr2820650634>3.0.co;2-5
41. Kaschwich M., Peters F., Hischke S., Rieß H.C., Gansel M., Marschall U., L’Hoest H., Heidemann F., Debus E.S., Acar L., Kreutzburg T., Behrendt C.A. Long-term incidence of cancer after index treatment for symptomatic peripheral arterial disease ‒ a health insurance claims data analysis. Vasa, 2020; 49 (6): 493‒499. doi: 10.1024/0301-1526/a000901
42. Navi B.B., Reiner A.S., Kamel H., Iadecola C., Elkind M.S., Panageas K.S., DeAngelis L.M. OC-02 ‒ Risk of arterial thromboembolism in patients with breast cancer. Thromb. Res., 2016; 140 Suppl 1: S169. doi: 10.1016/S0049-3848(16)30119-0
43. González Rodríguez P., Gisbert S.M.M., Chiriboga Granja J.I., Medina M.C., Palonés F.J.G. Anaplastic thyroid tumor as an embolic source of metastasis. J. Vasc. Surg. Cases Innov. Tech., 2022; 8 (3): 386‒389. doi: 10.1016/j.jvscit.2022.05.006
44. Lioudaki S., Kontopodis N., Palioudakis S., Koutsopoulos A.V., Drositis I., Ioannou C.V. Acute aortic occlusion due to tumor embolism in a patient with lung malignancy. SAGE Open Med. Case Rep., 2017; 5: 2050313X17720627. doi: 10.1177/2050313X17720627
45. Almatari A.L., Sathe A., Wideman L., Dewan C.A., Vaughan J.P., Bennie I.C., Buscarini M. Renal cell carcinoma with tumor thrombus: A review of relevant anatomy and surgical techniques for the general urologist. Urol. Oncol., 2023; 41 (4): 153‒165. doi: 10.1016/j.urolonc.2022.11.021
46. Sadat U., Noor N., See T.C., Varty K. Peripheral arterial ischemia by a primary lung tumour invading left atrium. Lung Cancer, 2007; 57 (2): 237‒239. doi: 10.1016/j.lungcan.2007.02.001
47. Navi B.B., Reiner A.S., Kamel H., Iadecola C., Okin P.M., Tagawa S.T., Panageas K.S., DeAngelis L.M. Arterial thromboembolic events preceding the diagnosis of cancer in older persons. Blood, 2019; 133 (8): 781‒789. doi: 10.1182/blood-2018-06-860874
48. Yu J., Li A., Laureano M., Crowther M. Frequency of arterial thromboembolism in populations with malignancies: A systematic review. Thromb. Res., 2019; 184: 16‒23. doi: 10.1016/j.thromres.2019.10.004
49. Vavlukis M., Kotlar I., Chaparoska E., Antova E., Kedev S. Diffuse arterial thrombosis as a first manifestation of occult malignancy. Case Rep. Med., 2016; 2016: 1658392. doi: 10.1155/2016/1658392
50. Palumbo A., Cavo M., Bringhen S., Zamagni E., Romano A., Patriarca F., Rossi D., Gentilini F., Crippa C., Galli M., Nozzoli C., Ria R., Marasca R., Montefusco V., Baldini L., Elice F., Callea V., Pulini S., Carella A.M., Zambello R., Benevolo G., Magarotto V., Tacchetti P., Pescosta N., Cellini C., Polloni C., Evangelista A., Caravita T., Morabito F., Offidani M., Tosi P., Boccadoro M. Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial. J. Clin. Oncol., 2011; 29 (8): 986‒993. doi: 10.1200/JCO.2010.31.6844
51. Landolfi R., Marchioli R., Kutti J., Gisslinger H., Tognoni G., Patrono C., Barbui T. European Collaboration on Low-Dose Aspirin in Polycythemia Vera Investigators. Efficacy and safety of low-dose aspirin in polycythemia vera. N. Engl. J. Med., 2004; 350 (2): 114‒124. doi: 10.1056/NEJMoa035572
52. Xu Y., Mallity C., Collins E., Siegal D.M., Wang T.F., Carrier M. Anticoagulation for the prevention of arterial thromboembolism in cancer patients by primary tumor site: a systematic review and meta-analysis of randomized trials. Eur. Heart J. Cardiovasc. Pharmacother., 2025; 10 (8): 665‒675. doi: 10.1093/ehjcvp/pvae068
53. Xu Y., Cole K., Collins E., Moledina A., Mallity C., Carrier M. Anticoagulation for the prevention of arterial thrombosis in ambulatory cancer patients: systematic review and meta-analysis. JACC CardioOncol., 2023; 5 (4): 520‒532. doi: 10.1016/j.jaccao.2023.04.003
54. Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., Cutter D.J., de Azambuja E., de Boer R.A., Dent S.F., Farmakis D., Gevaert S.A., Gorog D.A., Herrmann J., Lenihan D., Moslehi J., Moura B., Salinger S.S., Stephens R., Suter T.M., Szmit S., Tamargo J., Thavendiranathan P., Tocchetti C.G., van der Meer P., van der Pal H.J.H. ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur. Heart. J., 2022; 43 (41): 4229‒4361. doi: 10.1093/eurheartj/ehac244
55. Gevaert S.A., Halvorsen S., Sinnaeve P.R., Sambola A., Gulati G., Lancellotti P., van der Meer P., Lyon A.R., Farmakis D., Lee G., Boriani G., Wechalekar A., Okines A., Asteggiano R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases. Eur. Heart J. Acute Cardiovasc. Care, 2021; 10 (8): 947‒959. doi: 10.1093/ehjacc/zuab056
56. Harnarayan P., Islam S., Naraynsingh V. Arterial embolism in malignancy: the role of surgery. Ther. Clin. Risk Manag., 2021; 17: 635‒640. doi: 10.2147/TCRM.S308026
57. Hussain S.M.A. Lung cancer embolization causing acute limb ischemia: a case report. J. Med. Case Rep., 2023; 17 (1): 56. doi: 10.1186/s13256-023-03769-5
58. Sato A., Matsumoto A., Naruse S., Isono Y., Maeda Y., Yamada M., Ikeda T., Sasajima Y., Jinno H. Acute arterial occlusive disease due to tumor thrombus from lung metastasis of breast cancer with cartilaginous and osseous metaplasia: a case report. Surg. Case Rep., 2023; 9 (1): 13. doi: 10.1186/s40792023-01598-8
59. Tsubouchi K., Ibusuki R., Makisumi K., Okamoto H., Iwasaki T., Okamatsu Y., Inoue K., Harada T. Tumor embolism as a cause of renal artery occlusion and acute Kidney injury diagnosed and treated with endovascular intervention in a patient with mediastinal undifferentiated sarcoma. Intern. Med., 2021; 60 (12): 1907‒1910. doi: 10.2169/internalmedicine.6249-20
60. Aboyans V., Ricco J.B., Bartelink M.E.L., Björck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., de Carlo M., Debus S., Espinola-Klein C., Kahan T., Kownator S., Mazzolai L., Naylor A.R., Roffi M., Röther J., Sprynger M., Tendera M., Tepe G., Venermo M., Vlachopoulos C., Desormais I. ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO). The task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur. Heart J., 2018; 39 (9): 763‒816. doi: 10.1093/eurheartj/ehx095
Review
For citations:
Kozlov D.V., Zagorulko A.I., Nistratov G.P., Rykov S.P. Arterial thrombosis in patients with malignant diseases: definition, features, diagnostics, treatment. Literature review. Рart 2. Ateroscleroz. 2025;21(2):204-213. (In Russ.) https://doi.org/10.52727/2078-256X-2025-21-2-204-213
Views:
52
Email this article 